Cargando…
Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer
Lacking a satisfactory screening test, ovarian cancer is frequently diagnosed at a late stage, leading to poor patient outcomes. This study investigated the diagnostic value of circulating tumor cells (CTCs) in peripheral blood from patients with suspected ovarian tumors. Sixty-one women suspected o...
Autores principales: | Guo, Yan-Xiu, Neoh, Kuang Hong, Chang, Xiao-Hong, Sun, Yukun, Cheng, Hong-Yan, Ye, Xue, Ma, Rui-Qiong, Han, Ray P.S., Cui, Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800921/ https://www.ncbi.nlm.nih.gov/pubmed/29484129 http://dx.doi.org/10.18632/oncotarget.23943 |
Ejemplares similares
-
Evaluation of Circulating Endometrial Cells as a Biomarker for Endometriosis
por: Chen, Ying, et al.
Publicado: (2017) -
Diagnostic Value of Molecular Testing in Sonographically Suspicious Thyroid Nodules
por: Wang, Maxwell M, et al.
Publicado: (2020) -
Usefulness of the HE4 biomarker as a second-line test in the assessment of suspicious ovarian tumors
por: Moszynski, Rafal, et al.
Publicado: (2013) -
Microfluidic assay of circulating endothelial cells in coronary artery disease patients with angina pectoris
por: Chen, Shuiyu, et al.
Publicado: (2017) -
Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass
por: Partheen, Karolina, et al.
Publicado: (2011)